Analytical Data
-
Gene name
C13orf30
- Application
-
Alternative Names
Protein FAM216B
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q8N7L0
-
Expression Region
1-139aa
-
AA Sequence
MGQNWKRQQKLWNVPQLPFIRVPPSIYDTSLLKALNQGQQRYFYSIMRIYNSRPQWEALQTRYIHSLQHQQLLGYITQREALSYALVLRDSTKRASAKVAPQRTIPRKTSAMTRRCPSVLPVSVVLPRAQSKRRQVLRN
-
Molecular Weight
15.3 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
C13orf30, a gene located on chromosome 13, has garnered significant attention in the field of molecular biology due to its potential role in various cellular processes. Research on C13orf30 suggests it may be implicated in pathways related to immune response, cellular signaling, and possibly tumorigenesis. Its expression levels have been associated with certain diseases, making it a candidate for study in cancer biology and other conditions. The generation of recombinant C13orf30 protein allows for the exploration of its functional properties, including protein-protein interactions and signaling pathways. Understanding the biochemical characteristics of C13orf30 through its recombinant protein can provide insights into its role in health and disease and may uncover new therapeutic targets. Advanced techniques such as recombinant DNA technology enable the production of this protein in sufficient quantities for rigorous study, potentially paving the way for novel biomedical applications.











